Chair(s): Alexander M?ller, Marielle Pijnenburg, Susanne Vijverberg
Session type: Paediatric day
Fabio Midulla
Session content
Sejal Saglani
Replay
Slides
Will the new respiratory syncytial virus vaccination change the epidemiology and our practice?
Fabio Midulla
Replay
Slides
Pierluigi Ciet
Replay
Slides
Replay
Session aims
to present increasing evidence of clinical traits that may predict asthma; to discuss the new respiratory syncytial virus (RSV) vaccine which has the potential to change the epidemiology of RSV infections in infants and newborns and may also impact asthma development; to discus potential impacts; to discuss the Global Initiative for Asthma guidelines that provide evidence-based recommendations for the treatment of asthma and related controversy about how to implement these recommendations in daily practice.